05/01/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.52 |
Details |
Payment from |
Novo Nordisk Inc |
Payment Record ID |
669584381 |
|
01/22/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.61 |
Details |
Payment from |
PFIZER INC. |
Payment Record ID |
610098861 |
|
09/05/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.07 |
Details |
Payment from |
PFIZER INC. |
Payment Record ID |
610032839 |
|
07/20/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.54 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
596890913 |
|
05/08/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$19.09 |
Details |
Payment from |
Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Payment Record ID |
589632815 |
|
03/12/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.58 |
Details |
Payment from |
Novo Nordisk Inc |
Payment Record ID |
588706319 |
|
08/21/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.38 |
Details |
Payment from |
Novo Nordisk Inc |
Payment Record ID |
588706312 |
|
01/29/2018 |
Research |
In-kind items and services |
Drug |
$0.87 |
Details |
Payment from |
Eli Lilly and Company |
Paymment Research Study |
A PHASE 2, DOUBLE-BLIND, PLACEBO-CONTROLLED, 18-WEEK TRIAL OF INVESTIGATIONAL DULAGLUTIDE DOSES VERSUS PLACEBO IN PATIENTS WITH TYPE 2 DIABETES ON METFORMIN MONOTHERAPY |
Clinical Trials Gov ID |
NCT02973100 |
Payment Record ID |
585601001 |
|
02/13/2018 |
Research |
Cash or cash equivalent |
|
$6974.00 |
Details |
Payment from |
Eli Lilly and Company |
Paymment Research Study |
A PHASE 2 STUDY OF ONCE-WEEKLY LY3298176 COMPARED WITH PLACEBO AND DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS |
Clinical Trials Gov ID |
NCT03131687 |
Payment Record ID |
585600999 |
|
01/15/2018 |
Research |
In-kind items and services |
|
$579.30 |
Details |
Payment from |
Eli Lilly and Company |
Paymment Research Study |
A PHASE 2 STUDY OF ONCE-WEEKLY LY3298176 COMPARED WITH PLACEBO AND DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS |
Clinical Trials Gov ID |
NCT03131687 |
Payment Record ID |
585600997 |
|
01/23/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.73 |
Details |
Payment from |
Boston Scientific Corporation |
Payment Record ID |
548843685 |
|
11/13/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.51 |
Details |
Payment from |
PFIZER INC. |
Payment Record ID |
505974631 |
|
09/25/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$10.88 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
504377289 |
|
06/27/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$7.17 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
503983705 |
|
06/26/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$15.57 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
487889017 |
|
08/21/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.11 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
487456309 |
|
05/08/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$17.00 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
487033435 |
|
03/06/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.94 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
486889565 |
|
05/09/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.84 |
Details |
Payment from |
SANOFI PASTEUR INC. |
Payment Record ID |
486650461 |
|
01/19/2017 |
Research |
In-kind items and services |
Drug |
$218.30 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Paymment Research Study |
A 26-Week Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase 2 Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus |
Clinical Trials Gov ID |
NCT02973321 |
Payment Record ID |
486608319 |
|
01/19/2017 |
Research |
In-kind items and services |
Drug |
$310.01 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Paymment Research Study |
A 26-Week Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase 2 Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus |
Clinical Trials Gov ID |
NCT02973321 |
Payment Record ID |
486608317 |
|
01/19/2017 |
Research |
In-kind items and services |
Drug |
$148.40 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Paymment Research Study |
A 26-Week Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase 2 Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus |
Clinical Trials Gov ID |
NCT02973321 |
Payment Record ID |
486608311 |
|
01/19/2017 |
Research |
In-kind items and services |
Drug |
$167.36 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Paymment Research Study |
A 26-Week Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase 2 Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus |
Payment Record ID |
486608155 |
|
03/17/2017 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$63.80 |
Details |
Payment from |
Amgen Inc. |
Payment Record ID |
477926201 |
|
03/17/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$319.46 |
Details |
Payment from |
Amgen Inc. |
Payment Record ID |
477926198 |
|
03/17/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$203.90 |
Details |
Payment from |
Amgen Inc. |
Payment Record ID |
477926195 |
|
03/17/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$391.40 |
Details |
Payment from |
Amgen Inc. |
Payment Record ID |
477926191 |
|
03/17/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$119.00 |
Details |
Payment from |
Amgen Inc. |
Payment Record ID |
477926189 |
|
04/04/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$163.32 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
474928039 |
|
04/04/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$369.66 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
474928037 |
|
04/04/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$597.38 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
474928035 |
|
04/04/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$634.53 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
474928033 |
|
03/31/2017 |
General (Non-Research) |
Cash or cash equivalent |
Gift |
$2019.00 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
471296874 |
|
06/06/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.54 |
Details |
Payment from |
Astellas Pharma US Inc |
Payment Record ID |
465939715 |
|
10/04/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.43 |
Details |
Payment from |
Avanir Pharmaceuticals, Inc. |
Payment Record ID |
459378115 |
|
04/18/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$1006.95 |
Details |
Payment from |
Eli Lilly and Company |
Payment Record ID |
457154313 |
|
01/09/2017 |
Research |
In-kind items and services |
Drug |
$2305.36 |
Details |
Payment from |
Eli Lilly and Company |
Paymment Research Study |
A PHASE 2, DOUBLE-BLIND, PLACEBO-CONTROLLED, 18-WEEK TRIAL OF INVESTIGATIONAL DULAGLUTIDE DOSES VERSUS PLACEBO IN PATIENTS WITH TYPE 2 DIABETES ON METFORMIN MONOTHERAPY |
Clinical Trials Gov ID |
NCT02973100 |
Payment Record ID |
457096383 |
|
05/18/2017 |
Research |
In-kind items and services |
|
$12467.55 |
Details |
Payment from |
Eli Lilly and Company |
Paymment Research Study |
A PHASE 2 STUDY OF ONCE-WEEKLY LY3298176 COMPARED WITH PLACEBO AND DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS |
Clinical Trials Gov ID |
NCT03131687 |
Payment Record ID |
457096381 |
|
07/07/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$32.34 |
Details |
Payment from |
Valeant Pharmaceuticals North America LLC |
Payment Record ID |
444568533 |
|
04/19/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.99 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
406423052 |
|
06/28/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.46 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
406226996 |
|
08/16/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.63 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
405902116 |
|
01/14/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$90.95 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
405797602 |
|
01/15/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$71.27 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
405797600 |
|
01/15/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$64.36 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
405797554 |
|
01/14/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$591.52 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
405797552 |
|
01/15/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$49.99 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
405797550 |
|
01/15/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$47.89 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
405797548 |
|
01/15/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$34.99 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
405797546 |
|
01/14/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$251.55 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
405797544 |
|
01/14/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.90 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
405797542 |
|
01/20/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$119.76 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
405673754 |
|
08/09/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$19.61 |
Details |
Payment from |
Astellas Pharma US Inc |
Payment Record ID |
395734958 |
|
05/17/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$15.42 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394823892 |
|
08/10/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.44 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394666648 |
|
06/23/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$257.08 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394300656 |
|
06/23/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$507.40 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394300630 |
|
06/23/2016 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$31.13 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394300606 |
|
06/23/2016 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$39.59 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394300576 |
|
06/23/2016 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$48.00 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394300550 |
|
01/27/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.21 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394299382 |
|
06/23/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$175.88 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394283726 |
|
06/23/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$341.25 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
393782950 |
|
06/23/2016 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$50.00 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
393782914 |
|
09/21/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$155.68 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
392187626 |
|
04/19/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$300.78 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
392181673 |
|
09/21/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$149.64 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
391901294 |
|
09/21/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$273.72 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
391900516 |
|
09/21/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$666.99 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
391899546 |
|
04/19/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$41.11 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
391895266 |
|
04/20/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$390.15 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
391895258 |
|
04/19/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$630.54 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
391895246 |
|
04/19/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$204.20 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
391895238 |
|
05/09/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$17.28 |
Details |
Payment from |
Novo Nordisk Inc |
Payment Record ID |
390879298 |
|
11/17/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$41.82 |
Details |
Payment from |
Medtronic USA, Inc. |
Payment Record ID |
388358290 |
|
03/15/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.69 |
Details |
Payment from |
Amgen Inc. |
Payment Record ID |
386565008 |
|
03/02/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$10.85 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
379526894 |
|
11/16/2016 |
Research |
In-kind items and services |
Drug |
$3553.31 |
Details |
Payment from |
Eli Lilly and Company |
Paymment Research Study |
A PHASE 2, DOUBLE-BLIND, PLACEBO-CONTROLLED, 18-WEEK TRIAL OF INVESTIGATIONAL DULAGLUTIDE DOSES VERSUS PLACEBO IN PATIENTS WITH TYPE 2 DIABETES ON METFORMIN MONOTHERAPY |
Clinical Trials Gov ID |
NCT02973100 |
Payment Record ID |
372518034 |
|